Literature DB >> 11272877

Recurrent pleomorphic adenoma: uninodular versus multinodular disease.

H Rowley1, M Murphy, D Smyth, T P O'Dwyer.   

Abstract

BACKGROUND: While treatment of previously untreated pleomorphic adenoma is relatively straightforward, recurrent pleomorphic adenoma presents a management problem with increased risk of injury to the facial nerve and an increased risk of malignant transformation in recurrent disease. AIMS: The objectives of this study were to review the management of recurrent pleomorphic adenoma in our unit to identify factors that might help treatment of future cases.
METHODS: We reviewed the management of pleomorphic adenoma at our department over an eight-year period from 1990-1998 and present our experience of recurrent pleomorphic adenoma of the parotid gland and parapharyngeal space.
RESULTS: Twelve patients were treated with recurrent pleomorphic adenoma. In 10 of these, the site of recurrence was in the parotid gland with the remainder occurring in the parapharyngeal space. Type of recurrence was uninodular or multinodular, the former being easier to treat. Three patients required adjuvant radiotherapy. None of our patients had permanent facial nerve damage.
CONCLUSIONS: In order to prevent recurrence of pleomorphic adenoma of the parotid gland, we recommend formal superficial parotidectomy for first time surgery.

Entities:  

Mesh:

Year:  2000        PMID: 11272877     DOI: 10.1007/bf03167696

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  11 in total

1.  Recurrent mixed tumors of the parotid gland--results of surgical therapy.

Authors:  W E Fee; D R Goffinet; T C Calcaterra
Journal:  Laryngoscope       Date:  1978-02       Impact factor: 3.325

2.  A modified centripetal approach to parotidectomy.

Authors:  D Z Wang; S J Liu; R B Donoff; W Guralnick
Journal:  J Oral Maxillofac Surg       Date:  1985-01       Impact factor: 1.895

3.  Facial nerve in recurrent benign pleomorphic adenoma.

Authors:  J Conley; A A Clairmont
Journal:  Arch Otolaryngol       Date:  1979-05

4.  Mixed tumors of salivary glands. Long-term follow-up.

Authors:  S O Krolls; R C Boyers
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

5.  Recurrent pleomorphic adenoma of the parotid.

Authors:  W B Fleming
Journal:  Aust N Z J Surg       Date:  1987-03

6.  Influence of local surgery and radiotherapy on the natural history of pleomorphic adenomas.

Authors:  G T Watkin; M Hobsley
Journal:  Br J Surg       Date:  1986-01       Impact factor: 6.939

7.  Surgical treatment of recurrent pleomorphic adenoma of the parotid gland.

Authors:  J K Niparko; M L Beauchamp; C J Krause; S R Baker; W P Work
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1986-11

8.  Simple enucleation and radiotherapy in the treatment of the pleomorphic salivary adenoma of the parotid gland.

Authors:  P R Armitstead; F G Smiddy; H G Frank
Journal:  Br J Surg       Date:  1979-10       Impact factor: 6.939

9.  Recurrent pleomorphic adenomas of the parotid gland.

Authors:  A G Maran; I J Mackenzie; R E Stanley
Journal:  Arch Otolaryngol       Date:  1984-03

10.  Recurrent pleomorphic adenoma.

Authors:  S R Jackson; N J Roland; R W Clarke; A S Jones
Journal:  J Laryngol Otol       Date:  1993-06       Impact factor: 1.469

View more
  3 in total

1.  Imaging characteristics of recurrent pleomorphic adenoma of the parotid gland.

Authors:  G Moonis; P Patel; Y Koshkareva; J Newman; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

2.  Salivary Gland Pleomorphic Adenomas Presenting With Extremely Varied Clinical Courses. A Single Institution Case-Control Study.

Authors:  Krzysztof Piwowarczyk; Ewelina Bartkowiak; Paweł Kosikowski; Jadzia Tin-Tsen Chou; Małgorzata Wierzbicka
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

3.  Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature.

Authors:  Luca Oscar Redaelli de Zinis; Michela Piccioni; Antonino Roberto Antonelli; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-25       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.